ChanRx Corp.

CHANRX

CHAN RX;Biochemical research and development; Biomedical research services; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Drug discovery services; Medical research; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Scientific research; Scientific research and development;

CHANRX

Cardiovascular pharmaceuticals;Pharmaceutical and medical research in the field of the cardiovascular system and cardiovascular conditions, including research concerning arrhythmia, atrial fibrillation, atrial flutter and sinus rhythm;

CHANRX

The mark consists of the term ChanRX with a design element consisting of a curved band with three points appearing above the letter X.;Cardiovascular pharmaceuticals;CHAN RX;Color is not claimed as a feature of the mark.;Pharmaceutical and medical research in the field of the cardiovascular system and cardiovascular conditions, including research concerning arrhythmia, atrial fibrillation, atrial flutter and sinus rhythm;